Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

TXG
10x Genomics, Inc. Class A Common Stock
stock NASDAQ

Market Open
Aug 11, 2026 1:23:55 PM EDT
60.33USD+2.917%(+1.71)2,424,257
60.27Bid   63.50Ask   3.23Spread
Pre-market
Aug 11, 2026 9:29:30 AM EDT
58.60USD-0.034%(-0.02)1,894
After-hours
Aug 10, 2026 4:40:30 PM EDT
58.57USD-0.085%(-0.05)0
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 26, 2022
04:06PM EST  10x Genomics to Report Fourth Quarter and Full Year 2021 Financial Results on   PR Newswire
Jan 21, 2022
09:07AM EST  10x Genomics Announces Expansion Of 10x Certified Service Provider To Include Three Clinical Research Organizations   Benzinga
09:01AM EST  10x Genomics Adds Global Clinical Research Organizations to Expanded Certified   PR Newswire
Jan 11, 2022
10:38AM EST  52 Weeks High And Low Article   Benzinga
Dec 22, 2021
04:05PM EST  10x Genomics to Present Virtually at the 40th Annual J.P. Morgan Healthcare   PR Newswire
Dec 1, 2021
05:07PM EST  10x Genomics Recognized on The Scientist's Top 10 Innovations List for Fifth   PR Newswire
Nov 4, 2021
10:40AM EDT  Morgan Stanley Maintains Overweight on 10x Genomics, Lowers Price Target to $205   Benzinga
07:41AM EDT  10x Genomics Clocks 74% Jump In Q3 Revenues; Raises Top End Of Sales Guidance   Benzinga
Nov 3, 2021
05:05PM EDT  10x Genomics Q3 EPS $(0.15) Beats $(0.20) Estimate, Sales $125.30M Beat $122.62M Estimate   Benzinga
04:06PM EDT  10x Genomics Reports Third Quarter 2021 Financial Results   PR Newswire
09:19AM EDT  The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering   Benzinga
09:10AM EDT  Earnings Scheduled For November 3, 2021   Benzinga
Nov 2, 2021
11:48AM EDT  Earnings Preview: 10x Genomics   Benzinga
11:29AM EDT  10x Genomics Earnings Preview   Benzinga
Oct 31, 2021
02:24PM EDT  The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline   Benzinga
Oct 25, 2021
06:01AM EDT  10x Genomics Celebrates Opening of Singapore Manufacturing and Commercial Hub   PR Newswire
Oct 7, 2021
04:05PM EDT  10x Genomics to Report Third Quarter Financial Results on November 3, 2021   PR Newswire
Sep 23, 2021
06:30AM EDT  Not for distribution to United States newswire services or for dissemination in the United States   GlobeNewswire Inc
Sep 16, 2021
10:07AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2021   Benzinga
Sep 14, 2021
08:01AM EDT  B of A Securities Downgrades 10x Genomics to Neutral, Announces $180 Price Target   Benzinga
Aug 31, 2021
04:05PM EDT  10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating in the Morgan Stanley 19th Annual Global Healthcare Conference.   GlobeNewswire Inc
Aug 20, 2021
02:36PM EDT  Looking into 10x Genomics's Return on Capital Employed   Benzinga
Aug 10, 2021
02:42PM EDT  The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs   Benzinga
Aug 6, 2021
08:00AM EDT  10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating in the upcoming UBS Genomics 2.0 and MedTech Innovations Summit.   GlobeNewswire Inc
Aug 5, 2021
09:45AM EDT  Citigroup Maintains Buy on 10x Genomics, Lowers Price Target to $220   Benzinga
04:08AM EDT  Earnings Scheduled For August 5, 2021   Benzinga
Aug 4, 2021
05:05PM EDT  10x Genomics Q2 EPS $(0.10) Beats $(0.26) Estimate, Sales $115.85M Beat $112.85M Estimate; Reaffirms FY21 Sales Guidance $480M-$500M vs $496.5M Est.   Benzinga
04:05PM EDT  10x Genomics, Inc. (Nasdaq: TXG) today reported financial results for the second quarter ended June30, 2021.   GlobeNewswire Inc
04:10AM EDT  Earnings Scheduled For August 4, 2021   Benzinga
Jul 28, 2021
07:33AM EDT  The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal   Benzinga
Jul 27, 2021
12:28PM EDT  10x Genomics Entered Global Settlement And Patent Cross License With Bio-Rad Laboratories Resolving All Outstanding Litigation; Co. To Pay Bio-Rad $29.4M In Royalties And Interest Related To GEM Product Sales   Benzinga
06:30AM EDT  Agreement to Cross License Single Cell Technologies Ends all Ongoing Legal Disputes   GlobeNewswire Inc
06:16AM EDT  10x Genomics Entered Global Settlement And Patent Cross License With Bio-Rad Laboratories Resolving All Outstanding Litigation; Co. To Pay Bio-Rad $29.4M In Royalties And Interest Related To GEM Product Sales   Benzinga
Jul 14, 2021
08:16AM EDT  10x Genomics Introduces Chromium X Series For Single Cell Analysis   Benzinga
Jul 7, 2021
04:03PM EDT  10x Genomics (Nasdaq: TXG) today announced it will report financial results for the second quarter 2021 after market close on Wednesday, August 4th, 2021. The companys management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook.   GlobeNewswire Inc
Jun 30, 2021
07:29AM EDT  The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs   Benzinga
Jun 18, 2021
07:46AM EDT  The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs   Benzinga
Jun 10, 2021
08:00AM EDT  10x Genomics, Inc. (Nasdaq: TXG) today announced it is shipping its new Visium Spatial Gene Expression for FFPE (formalin-fixed and paraffin-embedded) assay. The offering gives researchers access to the whole transcriptome across their entire tissue, enabling true unbiased discovery in FFPE samples for the first time.   GlobeNewswire Inc
May 24, 2021
08:00AM EDT  10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating virtually in the following investor conferences:   GlobeNewswire Inc
May 13, 2021
08:49AM EDT  Recap: 10x Genomics Q1 Earnings   Benzinga
04:15AM EDT  Earnings Scheduled For May 13, 2021   Benzinga
May 6, 2021
07:49AM EDT  The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom   Benzinga
May 5, 2021
06:01PM EDT  10x Genomics Q1 Net Loss $11.6 Mln Vs Net Loss $21.1 Mln Last Year   RTTNews
04:22PM EDT  10x Genomics Q1 EPS $(0.11) Beats $(0.27) Estimate, Sales $105.82M Beat $102.51M Estimate   Benzinga
04:03PM EDT  10x Genomics, Inc. (Nasdaq: TXG) today reported financial results for the first quarter ended March31, 2021.   GlobeNewswire Inc
07:43AM EDT  The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues   Benzinga
04:16AM EDT  Earnings Scheduled For May 5, 2021   Benzinga
May 4, 2021
10:27AM EDT  10x Genomics's Earnings: A Preview   Benzinga
Apr 27, 2021
07:41AM EDT  The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout   Benzinga
Apr 15, 2021
07:49AM EDT  The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split   Benzinga
Apr 8, 2021
04:05PM EDT  10x Genomics (Nasdaq: TXG) today announced it will report financial results for the first quarter 2021 after market close on Wednesday, May 5th, 2021. The companys management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook.   GlobeNewswire Inc
Apr 1, 2021
08:46AM EDT  10x Genomics Announces Launch Of Its Chromium Single Cell Gene Expression Low Throughput Kit   Benzinga
08:30AM EDT  10x Genomics Puts Single Cell Analysis Within Reach of All With   GlobeNewswire Inc
Mar 15, 2021
11:09AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For March 15, 2021   Benzinga
08:40AM EDT  William Blair Initiates Coverage On 10x Genomics with Outperform Rating   Benzinga
Mar 9, 2021
08:30AM EST  10x Genomics Expands Pleasanton Headquarters with New Facilities   GlobeNewswire Inc
Feb 25, 2021
08:05AM EST  10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating in the upcoming 41st Annual Cowen Health Care Conference.   GlobeNewswire Inc
Feb 24, 2021
04:05PM EST  10x Genomics, Inc. (Nasdaq: TXG) today detailed a slew of new products and announced the acquisition of Copenhagen-based Tetramer Shop at its inaugural Xperience 2021 event, a showcase with three breakout sessions corresponding to 10xs three product platforms: Chromium Single Cell, Visium Spatial, and In Situ Analysis.   GlobeNewswire Inc
Feb 22, 2021
09:49AM EST  Morgan Stanley Maintains Overweight on 10x Genomics, Raises Price Target to $215   Benzinga
Feb 18, 2021
11:39AM EST  Cowen & Co. Maintains Outperform on 10x Genomics, Raises Price Target to $200   Benzinga
11:33AM EST  JP Morgan Maintains Overweight on 10x Genomics, Raises Price Target to $195   Benzinga
10:44AM EST  Citigroup Maintains Buy on 10x Genomics, Raises Price Target to $240   Benzinga
08:14AM EST  The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout   Benzinga
Feb 17, 2021
04:05PM EST  10x Genomics Sees FY21 Sales $480M-$500M vs $494.02M Est.   Benzinga
04:04PM EST  10x Genomics Q4 EPS $(3.87) Does Not Compare To $(0.23) Estimate, Sales $112.20M Beat $100.40M Estimate   Benzinga
04:03PM EST  10x Genomics Reports Fourth Quarter and Full Year 2020 Financial   GlobeNewswire Inc
04:34AM EST  Earnings Scheduled For February 17, 2021   Benzinga
Jan 21, 2021
08:05AM EST  The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping   Benzinga
Jan 15, 2021
07:57AM EST  The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges   Benzinga
Jan 12, 2021
08:16AM EST  The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue   Benzinga
Jan 7, 2021
10:26AM EST  ROCE Insights For 10x Genomics   Benzinga
Dec 23, 2020
04:03PM EST  10x Genomics (Nasdaq: TXG) today announced the company will be participating in the upcoming 39th Annual J.P. Morgan Virtual Healthcare Conference.   GlobeNewswire Inc
Dec 2, 2020
06:02AM EST  Goldman Sachs Initiates Coverage On 10x Genomics with Neutral Rating, Announces Price Target of $150   Benzinga
Nov 11, 2020
07:39AM EST  Morgan Stanley Maintains Overweight on 10x Genomics, Raises Price Target to $145   Benzinga
Nov 10, 2020
04:29PM EST  10x Genomics Q3 EPS $(0.65) Misses $(0.30) Estimate, Sales $71.80M Beat $61.23M Estimate   Benzinga
04:05PM EST  10x Genomics, Inc. (Nasdaq: TXG) today reported financial results for the third quarter ended September 30, 2020.   GlobeNewswire Inc
08:40AM EST  The Daily Biotech Pulse: Lilly's COVID-19 Antibody Treatment Approved For Emergency Use, Supernus Faces Twin Regulatory Setbacks, Revance, Arena Flunk Midstage Studies   Benzinga
Nov 8, 2020
03:58PM EST  The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions   Benzinga
12:47PM EST  The Week Ahead In Biotech: Earnings, Conference Presentations And IPOs   Benzinga
Oct 13, 2020
04:15PM EDT  10x Genomics (Nasdaq: TXG) today announced it will report financial results for the third quarter 2020 after market close on Tuesday, November 10, 2020. The companys management will webcast a corresponding conference call beginning at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time to discuss its results, business developments and outlook.   GlobeNewswire Inc
Oct 5, 2020
04:16PM EDT  10x Genomics Acquires ReadCoor For $350M In Cash And Stock   Benzinga
04:15PM EDT  10x Genomics Advances into Emerging Field of In Situ Analysis with   GlobeNewswire Inc
Sep 16, 2020
08:56AM EDT  B of A Securities Maintains Buy on 10x Genomics, Raises Price Target to $138   Benzinga
Sep 15, 2020
04:25PM EDT  10x Genomics Announces Closing of Public Offering and Full   GlobeNewswire Inc
12:06PM EDT  JP Morgan Maintains Overweight on 10x Genomics, Raises Price Target to $140   Benzinga
08:01AM EDT  10x Genomics First to Market With Product to Simultaneously   GlobeNewswire Inc
Sep 11, 2020
07:07AM EDT  10x Genomics Late Thursday Priced 4M Share Offering At $110/Share   Benzinga
12:14AM EDT  10x Genomics Prices IPO Of 4 Mln Shares Of Class A Common Stock At $110/Shr   RTTNews
Sep 10, 2020
11:27PM EDT  10x Genomics Announces Pricing Of Upsized Underwritten Public Offering At $110/shr   RTTNews
11:17PM EDT  10x Genomics Announces Pricing of Upsized Public Offering   GlobeNewswire Inc
Sep 9, 2020
06:02AM EDT  Morgan Stanley Initiates Coverage On 10x Genomics with Overweight Rating, Announces Price Target of $135   Benzinga
Sep 8, 2020
04:21PM EDT  10x Genomics Announces Launch of a Follow-On Public Offering   GlobeNewswire Inc
04:14PM EDT  10x Genomics S-1 Shows Registration For 3.5M Share Common Stock Offering   Benzinga
Sep 1, 2020
04:03PM EDT  10x Genomics (Nasdaq: TXG) today announced the company will be participating in the upcoming Morgan Stanley Virtual Healthcare Conference.   GlobeNewswire Inc
Aug 11, 2020
04:25PM EDT  10x Genomics Q2 Net Loss $40.2M vs Loss $10.9M, Sales $42.90M Beat $29.56M Estimate   Benzinga
04:06PM EDT  10x Genomics, Inc. (Nasdaq: TXG) today reported financial results for the second quarter ended June30, 2020.   GlobeNewswire Inc
04:02AM EDT  Earnings Scheduled For August 11, 2020   Benzinga
Aug 4, 2020
08:32AM EDT  Bio-Rad Labs Reports US Appeals Court Affirms 10x Genomics Willfully Infringed Bio-Rad Patent, Upholds Lower Courts Award Of Damages For $23.9M   Benzinga
Jul 20, 2020
10:48AM EDT  B of A Securities Maintains Buy on 10x Genomics, Raises Price Target to $105   Benzinga
Jul 14, 2020
09:02AM EDT  10x Genomics Highlights Launch Of Immune Profiling Product To Combat Coronavirus Infection   Benzinga
09:01AM EDT  10x Genomics Launches Next Generation Immune Profiling Product to   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC